Company / Operating Income per Share
Fulgent Genetics, Inc. Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.95
FY2025
5-year range
-$2.95 / $22.96
FY2021-FY2025
Trend
-18.5%
vs FY2024
Sector context
#143 of 154
Health Care
What the data says
Among 154 Health Care companies, Fulgent Genetics, Inc. is in the bottom 7% for operating income per share. Operating Income per Share has fluctuated over the past 10 years, ranging from $-2.95 in FY2025 to $22.96 in FY2023.
Based on SEC 10-K filings.
-2.95 in FY2025.
Declined from $22.96 to $-2.95 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 154This company -$2.95 Sector average $4.25
▼
-169.4% below sector average
Key checks
Key Insights
- In FY2025, operating income per share decreased 18.5% year-over-year.
- Ranks #143 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.95 | -18.5% |
| FY2024 | -$2.49 | -110.9% |
| FY2023 | $22.96 | +138.7% |
| FY2022 | $9.62 | +63438.8% |
| FY2021 | -$0.02 | -100.1% |
| FY2020 | $13.51 | +4941.0% |
| FY2019 | -$0.28 | -43.0% |
| FY2018 | -$0.20 | +1.0% |
| FY2017 | -$0.20 | -251.7% |
| FY2016 | -$0.06 | +86.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026